Anthim (obiltoxaximab)
Contract Overview
Contract Amount: $124,523,123 ($124.5M)
Contractor: Elusys Therapeutics Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2024-05-01
End Date: 2028-12-31
Official Description: ANTHIM (OBILTOXAXIMAB)